A Case of Carbamazepine-Induced Aggravation of Self-Limited Epilepsy with Centrotemporal Spikes Epilepsy and Valproate-Induced Hyperammonemic Encephalopathy in a Child with Heterozygous Gene Variant of Carbomoyl Phosphatase Synthetase Deficiency

Antiepileptics drugs are the mainstay of the management of epilepsy in children. Sodium valproate (VPA) and carbamazepine (CBZ) are widely used medications in childhood epilepsy. Hyperammonemia has been described as a known side effect of valproate therapy. It is known that VPA-associated HA is comm...

Descripción completa

Detalles Bibliográficos
Autores principales: Kankananarachchi, Imalke, Jasinge, Eresha, Hewawitharana, Gemunu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741391/
https://www.ncbi.nlm.nih.gov/pubmed/35003817
http://dx.doi.org/10.1155/2021/2362679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741391/
https://www.ncbi.nlm.nih.gov/pubmed/35003817
http://dx.doi.org/10.1155/2021/2362679

Ejemplares similares